Growth Metrics

Invivyd (IVVD) Receivables - Other (2021 - 2025)

Invivyd posted quarterly Receivables - Other of $676000.0 for Q4 2025, up 157.03% year-on-year from $263000.0 in Q4 2024, and up 139.72% on a QoQ basis from $282000.0 in Q3 2025.

Invivyd (IVVD) has 5 years of Receivables - Other data on file, last reported at $676000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 157.03% year-over-year to $676000.0; the trailing twelve-month figure through Dec 2025 stood at $676000.0 (up 157.03% YoY), and the FY2025 full-year result was $676000.0, up 157.03% from the prior year.
  • Receivables - Other for Q4 2025 stood at $676000.0, up from $282000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $933000.0 in Q4 2023 and bottomed at $111000.0 in Q2 2025.
  • The 5-year median for Receivables - Other is $460000.0 (2024), against an average of $502692.3.
  • Peak annual rise in Receivables - Other reached 157.03% in 2025, while the deepest fall reached 82.63% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $229000.0 in 2021, then soared by 64.63% to $377000.0 in 2022, then jumped by 147.48% to $933000.0 in 2023, then slumped by 71.81% to $263000.0 in 2024, then surged by 157.03% to $676000.0 in 2025.
  • The last three Receivables - Other figures came in at $676000.0 (Q4 2025), $282000.0 (Q3 2025), and $111000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Invivyd 208.38 Mn -18.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 676,000.00
Dec 31, 2025 676,000.00
Sep 30, 2025 282,000.00
Sep 30, 2025 282,000.00
Jun 30, 2025 111,000.00
Jun 30, 2025 111,000.00
Mar 31, 2025 192,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 263,000.00
Dec 31, 2024 263,000.00
Sep 30, 2024 460,000.00
Sep 30, 2024 460,000.00
Jun 30, 2024 639,000.00
Jun 30, 2024 639,000.00
Mar 31, 2024 875,000.00
Mar 31, 2024 875,000.00
Dec 31, 2023 933,000.00
Dec 31, 2023 933,000.00
Sep 30, 2023 713,000.00
Sep 30, 2023 713,000.00
Dec 31, 2022 377,000.00
Dec 31, 2022 377,000.00
Sep 30, 2022 785,000.00
Sep 30, 2022 785,000.00
Dec 31, 2021 229,000.00
Dec 31, 2021 229,000.00